Millennium Management

Caris Life Sciences, Inc. is a biotechnology company specializing in molecular profiling and advanced diagnostic technologies aimed at improving cancer patient outcomes. Founded in 1987 and headquartered in Irving, Texas, with additional offices in Phoenix and Basel, the company develops solutions that leverage artificial intelligence and machine learning to analyze the molecular complexity of diseases. Caris offers a range of services, including anatomic pathology, drug development, and molecular analyses of patient samples, which include genomic, transcriptomic, and proteomic profiling. Their Comprehensive Oncology Data Explorer serves as a clinico-genomic data platform. By providing insights into DNA, RNA, and protein profiles, Caris enables healthcare professionals to make more precise and personalized treatment decisions for oncology and other complex diseases. The company operates through distributors across the United States, Europe, Australia, and globally, and has established strategic collaborations to enhance its offerings.

Cardurion Pharmaceuticals, LLC is a biotechnology company based in Boston, Massachusetts, established in 2017. The company specializes in developing innovative therapeutics aimed at treating heart failure and other cardiovascular diseases. Cardurion is advancing clinical programs that focus on inhibiting PDE9 and CaMKII, utilizing its knowledge of cardiovascular signaling pathways to meet significant patient needs in this area.

Carmot Therapeutics, Inc. is a clinical-stage biotechnology company based in Berkeley, California, with an additional office in San Francisco. Founded in 2008, the company focuses on discovering and developing therapies for metabolic diseases, including obesity and diabetes. Carmot employs a proprietary drug discovery approach known as Chemotype Evolution, which enables the exploration of novel chemical and biological frontiers. The company is advancing a portfolio of clinical-stage drug candidates, including CT-388, a once-weekly injectable dual GLP-1/GIP receptor agonist; CT-996, a once-daily oral GLP-1 receptor agonist; and CT-868, a once-daily injectable dual GLP-1/GIP receptor agonist for treating type 1 diabetes in patients with overweight or obesity. These innovative therapies aim to enhance glucose clearance and promote weight loss, addressing the fundamental causes of metabolic diseases.

One97 Communications Limited is a mobile payments services company based in Noida, India, founded in 2000. It operates under the Paytm brand, offering a comprehensive range of mobile content and commerce services. The company provides digital goods and services, including top-ups, ticket bookings, hotel reservations, music, videos, games, and other mobile content. Additionally, One97 Communications is a leading provider of payment solutions for e-commerce merchants, utilizing its RBI-approved semi-closed wallet. With a workforce of over 4,500 employees, the company has a wide geographical footprint, with regional offices in major Indian cities such as Mumbai, Bengaluru, Pune, Chennai, and Kolkata, as well as a global presence in Africa, Europe, the Middle East, and Southeast Asia.

Metagenomi, Inc. is a biotechnology company focused on developing gene editing systems aimed at treating genetic diseases. Founded in 2016 and based in Emeryville, California, Metagenomi utilizes metagenomics and machine learning to uncover novel genome editing technologies derived from previously uncharacterized organisms. The company's innovative discovery platform enables the creation of highly efficient and specific gene editing tools, including programmable nucleases, base editors, and advanced integration systems such as prime editing and CRISPR-associated transposases. By harnessing these naturally evolved systems, Metagenomi seeks to address a wide range of genetic mutations that traditional genome engineering approaches have struggled to target, with the ultimate goal of providing transformative therapies for patients globally.

HFCL Limited is a company that focuses on the manufacturing of telecommunication equipment. It provides a range of products and services aimed at enhancing communication infrastructure. HFCL plays a vital role in supporting the growing demand for advanced telecommunications solutions, contributing to the development of both domestic and international communication networks. The company is involved in various sectors, including broadband, mobile, and data communication, thereby facilitating connectivity and technological advancement. Through its innovative offerings, HFCL aims to address the evolving needs of the telecommunications industry.

Palladyne AI is a software company specializing in advanced robotic technology that enhances the intelligence and efficiency of robotic systems. By leveraging artificial intelligence and machine learning, Palladyne AI's platform enables robots to observe, learn, reason, and act in ways that closely resemble human intelligence. This innovative software empowers robots to autonomously adapt to dynamic environments, allowing them to perceive and respond to changes in real-time. The applications of Palladyne AI's technology span various industries, including automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics, and warehousing, positioning the company as a key player in the evolution of robotics.

Market Kurly is an online premium grocery service that compares quality and price when looking for good ingredients for foreign goodies. Market Kurly is a food delivery and logistics platform that enables users to order food via the website and receive it the following morning. The company delivers fresh high-end desserts, bread, milk, bottled water, condiments such as flour & salt, processed foods, and more. The company was founded in 2015 and based in Seoul, South Korea.

Payoneer Inc. is a financial technology company that operates a cross-border payments platform designed to facilitate transactions for businesses and professionals worldwide. Founded in 2005 and headquartered in New York, Payoneer's services include the Global Payment Service, which allows users to receive local bank transfers from various countries directly into their Payoneer accounts. The platform also supports mass payouts, enabling companies, particularly in India, to transfer funds internationally. Payoneer caters to a diverse clientele, including freelancers, e-commerce businesses, and online advertising companies, and has established strategic partnerships to enhance its service offerings. Through its innovative solutions, Payoneer aims to empower small and medium-sized enterprises in the global digital commerce landscape.

Quanta is a medical devices company that develops advanced haemodialysis systems for use in the home and clinic. Quanta is focused on the commercialisation and ongoing development of SC+, an innovative cartridge-based haemodialysis system. SC+ is a high performance, compact haemodialysis system providing clinical efficacy by utilising typical flow rates of traditional in-centre machines. SC+ supports the entire ‘Continuum of Care’ for dialysis patients, from nurse-assisted treatment through self-care in centre to home haemodialysis. Their system facilitates the seamless transition between treatment modalities providing the best tool to enable flexibility for patients, and treatment options for physicians.

Caris Life Sciences, Inc. is a biotechnology company specializing in molecular profiling and advanced diagnostic technologies aimed at improving cancer patient outcomes. Founded in 1987 and headquartered in Irving, Texas, with additional offices in Phoenix and Basel, the company develops solutions that leverage artificial intelligence and machine learning to analyze the molecular complexity of diseases. Caris offers a range of services, including anatomic pathology, drug development, and molecular analyses of patient samples, which include genomic, transcriptomic, and proteomic profiling. Their Comprehensive Oncology Data Explorer serves as a clinico-genomic data platform. By providing insights into DNA, RNA, and protein profiles, Caris enables healthcare professionals to make more precise and personalized treatment decisions for oncology and other complex diseases. The company operates through distributors across the United States, Europe, Australia, and globally, and has established strategic collaborations to enhance its offerings.

Deep Instinct Ltd. is a cybersecurity company founded in 2014 and headquartered in Tel Aviv, Israel, with an additional office in New York. The company specializes in providing a cybersecurity solution that utilizes deep learning technology to offer on-device and real-time detection and prevention of advanced persistent threats and zero-day attacks. Its platform is designed to protect various mobile devices, endpoints, and operating systems against unknown and evasive cyber threats, regardless of whether they are connected to the network or the Internet. By leveraging the predictive capabilities of deep learning, Deep Instinct enables enterprises to identify and block cyber-attacks in real-time, ensuring comprehensive protection and reducing the risks associated with malware and other threats.

Starling Bank Limited is a digital-only bank based in London, United Kingdom, founded in 2014. It specializes in providing personal, joint, and business banking services through a mobile platform. The bank offers a range of financial services, including digital banking, real-time spending intelligence, and personalized banking options. Customers can manage their accounts entirely online, benefiting from features such as same-day payments and comprehensive financial management tools. Starling Bank aims to facilitate a seamless, paperless banking experience for its users.

WeDoctor is a prominent medical health technology platform founded in 2010 by Liao Jieyuan and his team. The company aims to enhance access to healthcare by leveraging technology to provide a comprehensive range of services. Its mobile application allows users to connect with hospitals and doctors, schedule appointments, and access medical advice and ratings for healthcare providers. By integrating both online and offline medical services, WeDoctor aspires to serve as a health management organization, facilitating improved healthcare experiences for millions of families. The platform emphasizes a user-friendly approach to healthcare, making essential medical services readily available and efficient.

SomaLogic, Inc. is a commercial-stage company based in Boulder, Colorado, specializing in protein biomarker discovery and clinical diagnostics. Founded in 1999, the company has developed advanced technologies such as SOMAmers, slow off-rate modified aptamers that specifically bind to target proteins, and the SOMAscan platform, which facilitates comprehensive protein measurement. This innovative approach allows for the analysis of protein biomarker signatures, significantly enhancing the understanding of health and disease beyond traditional genomic methods. SomaLogic's products are utilized in a variety of applications, including diagnostics for conditions in oncology, neurology, and cardiovascular and metabolic diseases, as well as in drug discovery and development. The company also offers diagnostic tests and protein measurement solutions for life science and biopharma researchers, contributing to advancements in medical science.

Caris Life Sciences, Inc. is a biotechnology company specializing in molecular profiling and advanced diagnostic technologies aimed at improving cancer patient outcomes. Founded in 1987 and headquartered in Irving, Texas, with additional offices in Phoenix and Basel, the company develops solutions that leverage artificial intelligence and machine learning to analyze the molecular complexity of diseases. Caris offers a range of services, including anatomic pathology, drug development, and molecular analyses of patient samples, which include genomic, transcriptomic, and proteomic profiling. Their Comprehensive Oncology Data Explorer serves as a clinico-genomic data platform. By providing insights into DNA, RNA, and protein profiles, Caris enables healthcare professionals to make more precise and personalized treatment decisions for oncology and other complex diseases. The company operates through distributors across the United States, Europe, Australia, and globally, and has established strategic collaborations to enhance its offerings.